Unilabs Announces Changes in its Executive Leadership Team

Geneva, 22 March 2023: Unilabs, a leading provider of diagnostic services, has announced three new leadership appointments to its executive team, effective 1 April 2023.

Betül Susamis Unaran will join Unilabs as Chief Commercial Officer. Britt Hendriksen will join Unilabs as Chief Financial Officer. Alessandre Keller has been appointed President of Central Europe and the Nordics.

Betül Susamis Unaran is an experienced healthcare leader with a proven track record of driving successful commercial and digital transformations. She has held leadership positions in Novartis Pharmaceuticals, Ferring Pharmaceuticals, and McKinsey & Company. Prior to joining Unilabs, she was Chief Strategy and Digital Officer at Zur Rose Group, Europe's largest online pharmacy, where she led the development of the European Healthcare Ecosystem.

Britt Hendriksen brings extensive healthcare knowledge and expertise from Novartis where she partnered with different businesses leading significant growth and led transformation initiatives over the past 20+ years. Prior to joining Unilabs, Britt was the Chief Financial Officer of Novartis’ Global Drug Development division. She brings extensive international experience, having lived in, and led diverse teams across both emerging and developed markets.

Alessandre Keller joined Unilabs in December 2019 as General Manager for Switzerland. Prior to joining Unilabs, Alessandre held various executive positions at Nestlé across Europe, Asia, and America.

“We are delighted to welcome Betül, Britt, and Alessandre to the Unilabs’ Executive Leadership Team. Their drive and passion for making a difference will be instrumental in our ambition to re-imagine Unilabs for a healthier tomorrow. I am confident that each of them will play a pivotal role in accelerating the business and achieving our future ambitions," said Unilabs’ Chairman of the Board of Directors, Marc Engel.